Project title: THERMODYNAMICS THERAPY FOR PROSTATE CANCER
Company name : BIOSPIRAL LTD.
TECHNOLOGICAL FIELD
Medical Devices
KEY WORDS
Urology, Cancer,
Prostate, Thermal Ablation, Minimal Invasive, Thermodynamics
PROJECT SUMMARY
BIOSPIRAL, an Israeli innovative medical device startup, is
developing a minimally invasive thermodynamics therapy for tissue
and tumor ablation.BIOSPIRAL is initially concentrates on
developing technologies for prostate cancer treatment. BIOSPIRALl
believes that its proprietary technologies have broad
applications across a number of markets, including the ablation
of tumors in the kidney, lung and liver.
The Challenge
Prostate cancer is the second most common type of cancer found
among males. Prostate cancer annual new cases worldwide:
~500,000.
Physicians, patients, insurance companies and health institutes
are seeking novel technology that will address the following
issues in prostate cancer treatments:
* Reduce side effects; incontinence, impotence .
* High efficiency treatment.
* Cost effectiveness.
* Patient friendly procedure.
BioSpiral Solution
BIOSPIRAL prostate thermodynamics therapy is an effective,
minimally invasive, outpatient treatment for prostate cancer. It
does not involve the difficulty and complications associated with
surgery, nor the harmful properties of radiation or cryotherapy
.The system revolutionizes prostate cancer treatment by
introducing a "one shot" treatment method under local anesthesia
/ sedation at the physician's clinic.
Key advantages:
* Highly efficient: complete & precise tissue ablation.
* Cost effective: short treatment, no need for O.R or
hospitalization.
* Patients wise: high quality of life; minimal side effects,
minimal invasive, short treatment & recovery.
* High Value for Payers, Physicians, Patients
BIOSPIRAL promotes its Thermodynamics proprietary technology for
a wide range of treatments and markets.
ENTREPRENEURS
Mr. Elazar Segal - CEO
Dr. Adrian Paz - Senior
Consultant
PROJECT STATUS
BioSpiral was established in Sep 2006 and is operating as part of
NGT Incubator. Currently BioSpiral is focusing on pre clinical &
clinical study.
Animal trials will be held H1 2007, Clinical trials H1 2008.
COOPERATION REQUIRED
BioSpiral is seeking strategic alliance & looking for beta site
for clinical trials.
------------------------------------------------
TEL: 972-4-6564118 972-52-4753399 FAX: 972-4-6564129 E-MAIL:
info@biospiral.com WEB: www.biospiral.com
Request for more information, about this project.
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please:
Register in this server
and your requests will be forwarded to the developer, who
will contact you directly
List of projects that you already requested more information about